GYL Financial Synergies LLC Buys New Stake in Walgreens Boots Alliance Inc (NASDAQ:WBA)

GYL Financial Synergies LLC bought a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm bought 4,460 shares of the pharmacy operator’s stock, valued at approximately $282,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in WBA. Colony Group LLC lifted its stake in shares of Walgreens Boots Alliance by 2.3% during the fourth quarter. Colony Group LLC now owns 6,142 shares of the pharmacy operator’s stock valued at $420,000 after buying an additional 141 shares during the period. Covington Capital Management raised its stake in Walgreens Boots Alliance by 11.1% during the fourth quarter. Covington Capital Management now owns 1,500 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 150 shares during the period. Barnett & Company Inc. raised its stake in Walgreens Boots Alliance by 11.1% during the fourth quarter. Barnett & Company Inc. now owns 1,501 shares of the pharmacy operator’s stock worth $103,000 after purchasing an additional 150 shares during the period. Mission Wealth Management LP raised its stake in Walgreens Boots Alliance by 5.9% during the fourth quarter. Mission Wealth Management LP now owns 3,124 shares of the pharmacy operator’s stock worth $213,000 after purchasing an additional 175 shares during the period. Finally, Beacon Investment Advisory Services Inc. raised its stake in Walgreens Boots Alliance by 3.2% during the fourth quarter. Beacon Investment Advisory Services Inc. now owns 5,668 shares of the pharmacy operator’s stock worth $387,000 after purchasing an additional 175 shares during the period. 61.52% of the stock is currently owned by institutional investors and hedge funds.

NASDAQ WBA traded up $0.12 during trading on Friday, reaching $55.74. The company’s stock had a trading volume of 3,826,083 shares, compared to its average volume of 6,042,030. Walgreens Boots Alliance Inc has a 1-year low of $49.31 and a 1-year high of $86.31. The company has a market capitalization of $50.23 billion, a PE ratio of 9.19, a PEG ratio of 1.34 and a beta of 0.82. The company has a quick ratio of 0.37, a current ratio of 0.76 and a debt-to-equity ratio of 0.49. The stock has a 50-day simple moving average of $52.88.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 EPS for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.05. The company had revenue of $34.59 billion for the quarter, compared to analyst estimates of $34.52 billion. Walgreens Boots Alliance had a net margin of 3.53% and a return on equity of 22.08%. The company’s quarterly revenue was up .7% compared to the same quarter last year. During the same quarter last year, the firm posted $1.53 earnings per share. On average, sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Tuesday, August 20th will be paid a $0.458 dividend. This represents a $1.83 annualized dividend and a dividend yield of 3.29%. The ex-dividend date of this dividend is Monday, August 19th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. Walgreens Boots Alliance’s payout ratio is currently 29.24%.

In related news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $53.05, for a total transaction of $1,061,000.00. Following the transaction, the chief accounting officer now owns 435,811 shares in the company, valued at approximately $23,119,773.55. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 15.73% of the stock is currently owned by insiders.

WBA has been the subject of several recent research reports. Barclays increased their price objective on shares of Stanley Black & Decker from $135.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 3rd. Mizuho set a $67.00 price target on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a report on Thursday, March 28th. UBS Group lowered shares of Guangshen Railway Co. Ltd ADR Class H from a “buy” rating to a “neutral” rating in a report on Wednesday, April 3rd. Morgan Stanley set a $61.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Tuesday, May 14th. Finally, Zacks Investment Research upgraded shares of Grana y Montero SAA from a “sell” rating to a “hold” rating in a research report on Monday, June 10th. Six equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company. Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus target price of $63.82.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Read More: Limitations to arbitrage trading

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.